Latest News about FDA
Recent news which mentions FDA
Sage Therapeutics, Biogen Start Rolling Submission For Zuranolone In Major Depressive Disorder
May 02, 2022
From Benzinga
Vaxxinity Gets Fast Track designation from FDA For Alzheimer's disease Candidate UB-311
May 02, 2022
Tickers
VAXX
From Benzinga
FDA Issues Complete Response Letter (CRL) to Axsome Therapeutics for AXS-07 In Acute Migraine
May 02, 2022
From Benzinga
U.S. FDA Rejects HUTCHMED's New Drug Application For Surufatinib In Neuroendocrine Tumors
May 02, 2022
Tickers
HCM
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Lyra Therapeutics Presents LYR-210 Positive Data from LANTERN Phase 2 Study for Chronic Rhinosinusitis
April 29, 2022
Tickers
LYRA
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.